CHA News

FDA Offers Guidance to Help Increase Supply of Certain Ibuprofen Products

This post has been archived and contains information that may be out of date.

The Food and Drug Administration (FDA) has issued guidance, effective immediately, on compounding certain ibuprofen oral suspension products in the wake of record high demand for the product. 

The FDA has received reports of increased demand for pediatric fever-reducing medications as a result of the tripledemic. Hospitals and health systems are experiencing challenges obtaining these medications to treat pediatric patients with fever, as well as adults who are unable to swallow solid oral dosage forms (e.g., people with feeding tubes).